rss
Thorax 2001;56:366-372 doi:10.1136/thorax.56.5.366
  • Original article

Assessment of airway neutrophils by sputum colour: correlation with airways inflammation

  1. R A Stockleya,
  2. D Bayleya,
  3. S L Hilla,
  4. A T Hilla,
  5. S Crooksa,
  6. E J Campbellb
  1. aDepartment of Medicine, Queen Elizabeth Hospital, Edgbaston, Birmingham B15 2TH, UK, bDepartment of Internal Medicine, University of Utah, Salt Lake City, UT, USA
  1. Professor R A Stockleyr.a.stockley{at}bham.ac.uk
  • Received 17 July 2000
  • Revision requested 19 January 2001
  • Revised 2 February 2001
  • Accepted 2 February 2001

Abstract

BACKGROUND Airway inflammation, with recruitment of neutrophils to the airway lumen, results in purulent secretions and a variety of potential adverse consequences for patients with chronic bronchitis and bronchiectasis. We hypothesised that gradations of sputum colour would correlate directly with the myeloperoxidase content of sputum and with various other indicators of the activity and consequences of bronchial diseases.

METHODS To test this hypothesis, we quantified sputum colour by reference to a sensitive nine point colour chart and correlated this assessment with indices of a number of inflammatory mediators in sputum.

RESULTS The results indicate that standardised visual measurements of sputum colour correlated strongly with myeloperoxidase, interleukin 8, leucocyte elastase (both activity and total quantity), sputum volume, protein leak, and secretory leucocyte proteinase inhibitor (p<0.001 for all). In addition, there was a strong direct correlation between leucocyte elastase and both myeloperoxidase (p<0.003) and sputum volume (p<0.001), but a strong negative correlation with secretory leucocyte proteinase inhibitor (p<0.001).

CONCLUSIONS These results indicate that sputum colour graded visually relates to the activity of the underlying markers of bronchial inflammation. The results of this simple visual analysis of sputum provides guidance concerning underlying inflammation and its damaging potential. It also provides a useful scientific tool for improving the monitoring of chronic airways diseases and response to treatment.

Footnotes

  • Funding: Supported in part by Zeneca Pharmaceuticals, Wilmington, DE, USA.

Register for free content


Free trial
Individuals may register for a free 30 day online trial to all content.

Free archive
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.